Eli Lilly plans $3.5 billion Pennsylvania plant for obesity drugs
Eli Lilly Chair and CEO Dave Ricks speaks during a press conference in Houston, Sept. 23, 2025.Antranik Tavitian | ReutersEli...
HEALTH & FITNESS
As ACA subsidies expire, voters cite health costs as major worry
The US Capitol in Washington, DC, US, on Tuesday, Jan. 27, 2026. Al Drago | Bloomberg | Getty ImagesHealth costs...
New drug fights neurological gene mutation
In 2016, when Susannah Rosen was 2½ years old, her parents, Luke Rosen and Sally Jackson, noticed during bath time...
15 drugs added to Medicare price negotiations
Boxes of the drug trulicity, made by Eli Lilly and Company, sit on a counter at a pharmacy in Provo,...
Danaher stock fails to rise on solid earnings — leading us to question what’s next
Danaher shares dropped on Wednesday because Wall Street was not giving the supplier of tools and equipment to drugmakers and...
UnitedHealth Group (UNH) earnings Q4 2025
UnitedHealth Group Inc. signage on the floor of the New York Stock Exchange (NYSE) in New York, US, on Wednesday,...
Next steps for Eli Lilly, Novo Nordisk, Pfizer
A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, Jan. 15, 2026.George Frey | Bloomberg...
Structure Therapeutics CEO on obesity pill and more
Ray Stevens, chief executive officer of Structure Therapeutics Inc., during a Bloomberg Television interview at the JPMorgan Healthcare Conference in...
Amazon launches AI health-care tool for One Medical members
Dr. Stephanie Long (right), MD, of One Medical Group takes the blood pressure of Danielle Greene (left), who is 20...
OpenEvidence, ‘ChatGPT for doctors,’ doubles valuation to $12 billion
A startup widely known as "ChatGPT for doctors" raised a new funding round that values the company at $12 billion....
Another alliance of health care and AI signals why pharma stocks could be back
Bristol Myers Squibb and Microsoft 's new partnership aimed at accelerating early detection of lung cancer marks the latest way...
Novo Nordisk, Pfizer execs weigh in
US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US,...
Keeping U.S. biotech ahead of China could aid rare disease patients: Experts
The growth of China's biotechnology sector has been staggering. Beijing is pumping money into the industry, backing research efforts and...
Novo Nordisk shares rise after Wegovy obesity pill launch
A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, US, on Thursday, Jan. 15, 2026....
Novo Nordisk CEO talks GLP-1 pill at JPMorgan conference
A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to...
OpenAI acquires health-care technology startup Torch
OpenAI has acquired the health-care technology startup Torch, the company announced on Monday. OpenAI purchased Torch for roughly $60 million,...
Thanks for your support, here’s how to connect with us
When Becky Quick announced the CNBC Cures initiative, our effort to raise awareness for rare diseases and improve the lives of the...
2026 is the year of obesity pills from Novo Nordisk, Eli Lilly
The booming GLP-1 space was built on weekly injections. In 2026, new obesity pills will push the market into its...
What to expect from pharma at the JPM conference
Heidi Overton, Novo Nordisk CEO Maziar Mike Doustdar, Eli Lilly CEO David A. Ricks, and U.S. Secretary of Commerce Howard...
Abivax’s stock surged to become a prime biotech takeover target
Europe's best-performing blue-chip stock in 2025 is widely expected to be bought by a larger peer, in a deal analysts...
